nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP3A4—type 2 diabetes mellitus	0.133	1	CbGaD
Morphine—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0811	0.149	CbGbCtD
Morphine—UGT1A3—Losartan—type 2 diabetes mellitus	0.0523	0.0963	CbGbCtD
Morphine—UGT2B7—Losartan—type 2 diabetes mellitus	0.0378	0.0696	CbGbCtD
Morphine—UGT1A1—Losartan—type 2 diabetes mellitus	0.0327	0.0601	CbGbCtD
Morphine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0283	0.0521	CbGbCtD
Morphine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0226	0.0416	CbGbCtD
Morphine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0215	0.0395	CbGbCtD
Morphine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0204	0.0376	CbGbCtD
Morphine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0191	0.0352	CbGbCtD
Morphine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0189	0.0347	CbGbCtD
Morphine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0182	0.0335	CbGbCtD
Morphine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0149	0.0273	CbGbCtD
Morphine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0138	0.0255	CbGbCtD
Morphine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.013	0.024	CbGbCtD
Morphine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0129	0.0237	CbGbCtD
Morphine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0222	CbGbCtD
Morphine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0115	0.0211	CbGbCtD
Morphine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0105	0.0193	CbGbCtD
Morphine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00988	0.0182	CbGbCtD
Morphine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00957	0.0176	CbGbCtD
Morphine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00951	0.0175	CbGbCtD
Morphine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00947	0.0174	CbGbCtD
Morphine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00917	0.0169	CbGbCtD
Morphine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00829	0.0153	CbGbCtD
Morphine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00708	0.013	CbGbCtD
Morphine—ABCB1—Losartan—type 2 diabetes mellitus	0.00648	0.0119	CbGbCtD
Morphine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00628	0.0116	CbGbCtD
Morphine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00602	0.0111	CbGbCtD
Morphine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00602	0.0111	CbGbCtD
Morphine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0057	0.0105	CbGbCtD
Morphine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00424	0.00781	CbGbCtD
Morphine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00388	0.00715	CbGbCtD
Morphine—UGT2B15—islet of Langerhans—type 2 diabetes mellitus	0.00136	0.107	CbGeAlD
Morphine—UGT1A8—kidney—type 2 diabetes mellitus	0.00115	0.0906	CbGeAlD
Morphine—OPRM1—nerve—type 2 diabetes mellitus	0.00115	0.0905	CbGeAlD
Morphine—UGT2B4—cardiovascular system—type 2 diabetes mellitus	0.00109	0.0861	CbGeAlD
Morphine—UGT2B15—pancreas—type 2 diabetes mellitus	0.000957	0.0755	CbGeAlD
Morphine—UGT1A8—liver—type 2 diabetes mellitus	0.000727	0.0573	CbGeAlD
Morphine—UGT2B4—liver—type 2 diabetes mellitus	0.000675	0.0533	CbGeAlD
Morphine—UGT1A3—liver—type 2 diabetes mellitus	0.000648	0.0511	CbGeAlD
Morphine—UGT2B15—liver—type 2 diabetes mellitus	0.000609	0.048	CbGeAlD
Morphine—UGT2B7—kidney—type 2 diabetes mellitus	0.000588	0.0464	CbGeAlD
Morphine—OPRD1—kidney—type 2 diabetes mellitus	0.000577	0.0455	CbGeAlD
Morphine—UGT1A1—kidney—type 2 diabetes mellitus	0.0005	0.0395	CbGeAlD
Morphine—UGT2B7—liver—type 2 diabetes mellitus	0.000372	0.0293	CbGeAlD
Morphine—UGT1A1—liver—type 2 diabetes mellitus	0.000316	0.0249	CbGeAlD
Morphine—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.000254	0.152	CrCbGaD
Morphine—CYP2C8—kidney—type 2 diabetes mellitus	0.000237	0.0187	CbGeAlD
Morphine—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.000223	0.133	CrCbGaD
Morphine—Ethylmorphine—CYP3A4—type 2 diabetes mellitus	0.000213	0.127	CrCbGaD
Morphine—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.000195	0.116	CrCbGaD
Morphine—Codeine—CYP3A4—type 2 diabetes mellitus	0.000169	0.101	CrCbGaD
Morphine—Naloxone—CYP3A4—type 2 diabetes mellitus	0.000162	0.0971	CrCbGaD
Morphine—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.000161	0.0964	CrCbGaD
Morphine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00016	0.0126	CbGeAlD
Morphine—CYP3A4—kidney—type 2 diabetes mellitus	0.00016	0.0126	CbGeAlD
Morphine—CYP2D6—kidney—type 2 diabetes mellitus	0.000158	0.0124	CbGeAlD
Morphine—Galantamine—CYP3A4—type 2 diabetes mellitus	0.000154	0.092	CrCbGaD
Morphine—CYP2C8—liver—type 2 diabetes mellitus	0.00015	0.0118	CbGeAlD
Morphine—Naloxone—ALB—type 2 diabetes mellitus	0.000142	0.0847	CrCbGaD
Morphine—ABCB1—retina—type 2 diabetes mellitus	0.000137	0.0108	CbGeAlD
Morphine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000129	0.0102	CbGeAlD
Morphine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000116	0.00915	CbGeAlD
Morphine—ABCB1—kidney—type 2 diabetes mellitus	0.000113	0.00895	CbGeAlD
Morphine—ABCB1—pancreas—type 2 diabetes mellitus	0.000113	0.00889	CbGeAlD
Morphine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000111	0.00872	CbGeAlD
Morphine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000102	0.00807	CbGeAlD
Morphine—CYP3A4—liver—type 2 diabetes mellitus	0.000101	0.00799	CbGeAlD
Morphine—CYP2D6—liver—type 2 diabetes mellitus	9.97e-05	0.00786	CbGeAlD
Morphine—Insomnia—Orlistat—type 2 diabetes mellitus	7.51e-05	0.000382	CcSEcCtD
Morphine—Malaise—Losartan—type 2 diabetes mellitus	7.51e-05	0.000382	CcSEcCtD
Morphine—Anxiety—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000382	CcSEcCtD
Morphine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.51e-05	0.000382	CcSEcCtD
Morphine—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.51e-05	0.000382	CcSEcCtD
Morphine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.49e-05	0.000381	CcSEcCtD
Morphine—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.49e-05	0.000381	CcSEcCtD
Morphine—Vertigo—Losartan—type 2 diabetes mellitus	7.48e-05	0.000381	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000381	CcSEcCtD
Morphine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.48e-05	0.000381	CcSEcCtD
Morphine—Somnolence—Valsartan—type 2 diabetes mellitus	7.47e-05	0.00038	CcSEcCtD
Morphine—Syncope—Losartan—type 2 diabetes mellitus	7.47e-05	0.00038	CcSEcCtD
Morphine—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000379	CcSEcCtD
Morphine—Leukopenia—Losartan—type 2 diabetes mellitus	7.46e-05	0.000379	CcSEcCtD
Morphine—Discomfort—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000379	CcSEcCtD
Morphine—Skin disorder—Metformin—type 2 diabetes mellitus	7.43e-05	0.000378	CcSEcCtD
Morphine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.4e-05	0.000377	CcSEcCtD
Morphine—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000376	CcSEcCtD
Morphine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000376	CcSEcCtD
Morphine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.37e-05	0.000375	CcSEcCtD
Morphine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000375	CcSEcCtD
Morphine—Palpitations—Losartan—type 2 diabetes mellitus	7.36e-05	0.000375	CcSEcCtD
Morphine—Nausea—Glimepiride—type 2 diabetes mellitus	7.34e-05	0.000373	CcSEcCtD
Morphine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.32e-05	0.000373	CcSEcCtD
Morphine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.32e-05	0.000372	CcSEcCtD
Morphine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000372	CcSEcCtD
Morphine—Asthenia—Glyburide—type 2 diabetes mellitus	7.31e-05	0.000372	CcSEcCtD
Morphine—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.31e-05	0.000372	CcSEcCtD
Morphine—Anorexia—Metformin—type 2 diabetes mellitus	7.3e-05	0.000371	CcSEcCtD
Morphine—Cough—Losartan—type 2 diabetes mellitus	7.27e-05	0.00037	CcSEcCtD
Morphine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.00037	CcSEcCtD
Morphine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000369	CcSEcCtD
Morphine—Fatigue—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000369	CcSEcCtD
Morphine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.23e-05	0.000368	CcSEcCtD
Morphine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.23e-05	0.000368	CcSEcCtD
Morphine—Oedema—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000368	CcSEcCtD
Morphine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000368	CcSEcCtD
Morphine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000367	CcSEcCtD
Morphine—Pruritus—Glyburide—type 2 diabetes mellitus	7.21e-05	0.000367	CcSEcCtD
Morphine—Mental disorder—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000366	CcSEcCtD
Morphine—Constipation—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000366	CcSEcCtD
Morphine—Infection—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000365	CcSEcCtD
Morphine—ABCB1—liver—type 2 diabetes mellitus	7.17e-05	0.00566	CbGeAlD
Morphine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000365	CcSEcCtD
Morphine—Fatigue—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000364	CcSEcCtD
Morphine—Hypotension—Metformin—type 2 diabetes mellitus	7.15e-05	0.000364	CcSEcCtD
Morphine—Erythema—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000363	CcSEcCtD
Morphine—Malnutrition—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000363	CcSEcCtD
Morphine—Shock—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000362	CcSEcCtD
Morphine—Pain—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000361	CcSEcCtD
Morphine—Chest pain—Losartan—type 2 diabetes mellitus	7.09e-05	0.000361	CcSEcCtD
Morphine—Arthralgia—Losartan—type 2 diabetes mellitus	7.09e-05	0.000361	CcSEcCtD
Morphine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.09e-05	0.000361	CcSEcCtD
Morphine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.00036	CcSEcCtD
Morphine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.00036	CcSEcCtD
Morphine—Anxiety—Losartan—type 2 diabetes mellitus	7.07e-05	0.00036	CcSEcCtD
Morphine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.000359	CcSEcCtD
Morphine—Rash—Bromocriptine—type 2 diabetes mellitus	7.03e-05	0.000358	CcSEcCtD
Morphine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.02e-05	0.000357	CcSEcCtD
Morphine—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000357	CcSEcCtD
Morphine—Tension—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000357	CcSEcCtD
Morphine—Discomfort—Losartan—type 2 diabetes mellitus	7.01e-05	0.000357	CcSEcCtD
Morphine—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000356	CcSEcCtD
Morphine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000355	CcSEcCtD
Morphine—Headache—Bromocriptine—type 2 diabetes mellitus	6.98e-05	0.000355	CcSEcCtD
Morphine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.97e-05	0.000355	CcSEcCtD
Morphine—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.97e-05	0.000355	CcSEcCtD
Morphine—Nervousness—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000353	CcSEcCtD
Morphine—Dry mouth—Losartan—type 2 diabetes mellitus	6.94e-05	0.000353	CcSEcCtD
Morphine—Anorexia—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.00035	CcSEcCtD
Morphine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.87e-05	0.00035	CcSEcCtD
Morphine—Paraesthesia—Metformin—type 2 diabetes mellitus	6.87e-05	0.00035	CcSEcCtD
Morphine—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000349	CcSEcCtD
Morphine—Confusional state—Losartan—type 2 diabetes mellitus	6.85e-05	0.000349	CcSEcCtD
Morphine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000348	CcSEcCtD
Morphine—Dyspnoea—Metformin—type 2 diabetes mellitus	6.82e-05	0.000347	CcSEcCtD
Morphine—Somnolence—Metformin—type 2 diabetes mellitus	6.8e-05	0.000346	CcSEcCtD
Morphine—Oedema—Losartan—type 2 diabetes mellitus	6.8e-05	0.000346	CcSEcCtD
Morphine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.8e-05	0.000346	CcSEcCtD
Morphine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.79e-05	0.000346	CcSEcCtD
Morphine—Infection—Losartan—type 2 diabetes mellitus	6.75e-05	0.000344	CcSEcCtD
Morphine—Hypotension—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000343	CcSEcCtD
Morphine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.74e-05	0.000343	CcSEcCtD
Morphine—Dyspepsia—Metformin—type 2 diabetes mellitus	6.74e-05	0.000343	CcSEcCtD
Morphine—Tremor—Ramipril—type 2 diabetes mellitus	6.69e-05	0.00034	CcSEcCtD
Morphine—Shock—Losartan—type 2 diabetes mellitus	6.69e-05	0.00034	CcSEcCtD
Morphine—Urticaria—Valsartan—type 2 diabetes mellitus	6.68e-05	0.00034	CcSEcCtD
Morphine—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.67e-05	0.000339	CcSEcCtD
Morphine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.66e-05	0.000339	CcSEcCtD
Morphine—Decreased appetite—Metformin—type 2 diabetes mellitus	6.65e-05	0.000339	CcSEcCtD
Morphine—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.64e-05	0.000338	CcSEcCtD
Morphine—Tachycardia—Losartan—type 2 diabetes mellitus	6.63e-05	0.000338	CcSEcCtD
Morphine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.63e-05	0.000337	CcSEcCtD
Morphine—Nausea—Bromocriptine—type 2 diabetes mellitus	6.62e-05	0.000337	CcSEcCtD
Morphine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.61e-05	0.000336	CcSEcCtD
Morphine—Fatigue—Metformin—type 2 diabetes mellitus	6.6e-05	0.000336	CcSEcCtD
Morphine—Urticaria—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000336	CcSEcCtD
Morphine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000335	CcSEcCtD
Morphine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.57e-05	0.000334	CcSEcCtD
Morphine—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000334	CcSEcCtD
Morphine—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000334	CcSEcCtD
Morphine—Asthenia—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000334	CcSEcCtD
Morphine—Agitation—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000334	CcSEcCtD
Morphine—Constipation—Metformin—type 2 diabetes mellitus	6.55e-05	0.000333	CcSEcCtD
Morphine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.00033	CcSEcCtD
Morphine—Anorexia—Losartan—type 2 diabetes mellitus	6.48e-05	0.00033	CcSEcCtD
Morphine—Vomiting—Glyburide—type 2 diabetes mellitus	6.48e-05	0.00033	CcSEcCtD
Morphine—Pruritus—Gliclazide—type 2 diabetes mellitus	6.47e-05	0.000329	CcSEcCtD
Morphine—Malaise—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000328	CcSEcCtD
Morphine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000328	CcSEcCtD
Morphine—Rash—Glyburide—type 2 diabetes mellitus	6.42e-05	0.000327	CcSEcCtD
Morphine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000327	CcSEcCtD
Morphine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.42e-05	0.000327	CcSEcCtD
Morphine—Vertigo—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000327	CcSEcCtD
Morphine—Syncope—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000326	CcSEcCtD
Morphine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000325	CcSEcCtD
Morphine—Headache—Glyburide—type 2 diabetes mellitus	6.38e-05	0.000325	CcSEcCtD
Morphine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000324	CcSEcCtD
Morphine—Hypotension—Losartan—type 2 diabetes mellitus	6.35e-05	0.000323	CcSEcCtD
Morphine—Palpitations—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000321	CcSEcCtD
Morphine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.31e-05	0.000321	CcSEcCtD
Morphine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.00032	CcSEcCtD
Morphine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000319	CcSEcCtD
Morphine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.26e-05	0.000319	CcSEcCtD
Morphine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.26e-05	0.000318	CcSEcCtD
Morphine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000317	CcSEcCtD
Morphine—Cough—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000317	CcSEcCtD
Morphine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000317	CcSEcCtD
Morphine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.19e-05	0.000315	CcSEcCtD
Morphine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000315	CcSEcCtD
Morphine—Convulsion—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000315	CcSEcCtD
Morphine—Constipation—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000314	CcSEcCtD
Morphine—Pain—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000314	CcSEcCtD
Morphine—Insomnia—Losartan—type 2 diabetes mellitus	6.15e-05	0.000313	CcSEcCtD
Morphine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.12e-05	0.000311	CcSEcCtD
Morphine—Paraesthesia—Losartan—type 2 diabetes mellitus	6.1e-05	0.000311	CcSEcCtD
Morphine—Urticaria—Metformin—type 2 diabetes mellitus	6.08e-05	0.000309	CcSEcCtD
Morphine—Chest pain—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000309	CcSEcCtD
Morphine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000309	CcSEcCtD
Morphine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.06e-05	0.000308	CcSEcCtD
Morphine—Anxiety—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000308	CcSEcCtD
Morphine—Nausea—Glyburide—type 2 diabetes mellitus	6.05e-05	0.000308	CcSEcCtD
Morphine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.05e-05	0.000308	CcSEcCtD
Morphine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.05e-05	0.000308	CcSEcCtD
Morphine—Somnolence—Losartan—type 2 diabetes mellitus	6.04e-05	0.000308	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000307	CcSEcCtD
Morphine—Asthenia—Valsartan—type 2 diabetes mellitus	6.03e-05	0.000307	CcSEcCtD
Morphine—Discomfort—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000306	CcSEcCtD
Morphine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.98e-05	0.000304	CcSEcCtD
Morphine—Asthenia—Orlistat—type 2 diabetes mellitus	5.96e-05	0.000303	CcSEcCtD
Morphine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000303	CcSEcCtD
Morphine—Pruritus—Valsartan—type 2 diabetes mellitus	5.95e-05	0.000303	CcSEcCtD
Morphine—Dry mouth—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000303	CcSEcCtD
Morphine—Decreased appetite—Losartan—type 2 diabetes mellitus	5.91e-05	0.000301	CcSEcCtD
Morphine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000301	CcSEcCtD
Morphine—Confusional state—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000299	CcSEcCtD
Morphine—Pruritus—Orlistat—type 2 diabetes mellitus	5.88e-05	0.000299	CcSEcCtD
Morphine—Fatigue—Losartan—type 2 diabetes mellitus	5.86e-05	0.000298	CcSEcCtD
Morphine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000297	CcSEcCtD
Morphine—Oedema—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000297	CcSEcCtD
Morphine—Vomiting—Gliclazide—type 2 diabetes mellitus	5.82e-05	0.000296	CcSEcCtD
Morphine—Pain—Losartan—type 2 diabetes mellitus	5.81e-05	0.000296	CcSEcCtD
Morphine—Constipation—Losartan—type 2 diabetes mellitus	5.81e-05	0.000296	CcSEcCtD
Morphine—Rash—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000294	CcSEcCtD
Morphine—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000293	CcSEcCtD
Morphine—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000293	CcSEcCtD
Morphine—Urticaria—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000292	CcSEcCtD
Morphine—Shock—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000292	CcSEcCtD
Morphine—Headache—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000292	CcSEcCtD
Morphine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000291	CcSEcCtD
Morphine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000291	CcSEcCtD
Morphine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000291	CcSEcCtD
Morphine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.71e-05	0.00029	CcSEcCtD
Morphine—Tachycardia—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000289	CcSEcCtD
Morphine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000289	CcSEcCtD
Morphine—Skin disorder—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000288	CcSEcCtD
Morphine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000287	CcSEcCtD
Morphine—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.6e-05	0.000285	CcSEcCtD
Morphine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.56e-05	0.000283	CcSEcCtD
Morphine—Dizziness—Valsartan—type 2 diabetes mellitus	5.56e-05	0.000283	CcSEcCtD
Morphine—Anorexia—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000283	CcSEcCtD
Morphine—Dizziness—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000279	CcSEcCtD
Morphine—Asthenia—Metformin—type 2 diabetes mellitus	5.49e-05	0.000279	CcSEcCtD
Morphine—Hypotension—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000277	CcSEcCtD
Morphine—Nausea—Gliclazide—type 2 diabetes mellitus	5.43e-05	0.000277	CcSEcCtD
Morphine—Pruritus—Metformin—type 2 diabetes mellitus	5.42e-05	0.000276	CcSEcCtD
Morphine—Urticaria—Losartan—type 2 diabetes mellitus	5.4e-05	0.000275	CcSEcCtD
Morphine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.37e-05	0.000273	CcSEcCtD
Morphine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.37e-05	0.000273	CcSEcCtD
Morphine—Vomiting—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000272	CcSEcCtD
Morphine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000271	CcSEcCtD
Morphine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.31e-05	0.00027	CcSEcCtD
Morphine—Rash—Valsartan—type 2 diabetes mellitus	5.3e-05	0.00027	CcSEcCtD
Morphine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000269	CcSEcCtD
Morphine—Vomiting—Orlistat—type 2 diabetes mellitus	5.28e-05	0.000269	CcSEcCtD
Morphine—Insomnia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000268	CcSEcCtD
Morphine—Headache—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000268	CcSEcCtD
Morphine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.24e-05	0.000266	CcSEcCtD
Morphine—Rash—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000266	CcSEcCtD
Morphine—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000266	CcSEcCtD
Morphine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000266	CcSEcCtD
Morphine—Headache—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000265	CcSEcCtD
Morphine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000264	CcSEcCtD
Morphine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000264	CcSEcCtD
Morphine—Somnolence—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000264	CcSEcCtD
Morphine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000261	CcSEcCtD
Morphine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.00026	CcSEcCtD
Morphine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000258	CcSEcCtD
Morphine—Dizziness—Metformin—type 2 diabetes mellitus	5.06e-05	0.000258	CcSEcCtD
Morphine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000256	CcSEcCtD
Morphine—Fatigue—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000256	CcSEcCtD
Morphine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.01e-05	0.000255	CcSEcCtD
Morphine—Nausea—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000254	CcSEcCtD
Morphine—Constipation—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000254	CcSEcCtD
Morphine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000251	CcSEcCtD
Morphine—Nausea—Orlistat—type 2 diabetes mellitus	4.93e-05	0.000251	CcSEcCtD
Morphine—Asthenia—Losartan—type 2 diabetes mellitus	4.88e-05	0.000248	CcSEcCtD
Morphine—Vomiting—Metformin—type 2 diabetes mellitus	4.87e-05	0.000248	CcSEcCtD
Morphine—Rash—Metformin—type 2 diabetes mellitus	4.83e-05	0.000246	CcSEcCtD
Morphine—Dermatitis—Metformin—type 2 diabetes mellitus	4.82e-05	0.000245	CcSEcCtD
Morphine—Pruritus—Losartan—type 2 diabetes mellitus	4.81e-05	0.000245	CcSEcCtD
Morphine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000244	CcSEcCtD
Morphine—Headache—Metformin—type 2 diabetes mellitus	4.8e-05	0.000244	CcSEcCtD
Morphine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000243	CcSEcCtD
Morphine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000243	CcSEcCtD
Morphine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.65e-05	0.000237	CcSEcCtD
Morphine—Urticaria—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000236	CcSEcCtD
Morphine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000234	CcSEcCtD
Morphine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000234	CcSEcCtD
Morphine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000234	CcSEcCtD
Morphine—Rash—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000232	CcSEcCtD
Morphine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000232	CcSEcCtD
Morphine—Nausea—Metformin—type 2 diabetes mellitus	4.55e-05	0.000231	CcSEcCtD
Morphine—Headache—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.00023	CcSEcCtD
Morphine—Dizziness—Losartan—type 2 diabetes mellitus	4.5e-05	0.000229	CcSEcCtD
Morphine—Vomiting—Losartan—type 2 diabetes mellitus	4.32e-05	0.00022	CcSEcCtD
Morphine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000219	CcSEcCtD
Morphine—Nausea—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000218	CcSEcCtD
Morphine—Rash—Losartan—type 2 diabetes mellitus	4.29e-05	0.000218	CcSEcCtD
Morphine—Dermatitis—Losartan—type 2 diabetes mellitus	4.28e-05	0.000218	CcSEcCtD
Morphine—Headache—Losartan—type 2 diabetes mellitus	4.26e-05	0.000217	CcSEcCtD
Morphine—Asthenia—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000213	CcSEcCtD
Morphine—Pruritus—Ramipril—type 2 diabetes mellitus	4.12e-05	0.00021	CcSEcCtD
Morphine—Nausea—Losartan—type 2 diabetes mellitus	4.04e-05	0.000205	CcSEcCtD
Morphine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000203	CcSEcCtD
Morphine—Dizziness—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000196	CcSEcCtD
Morphine—Vomiting—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000189	CcSEcCtD
Morphine—Rash—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000187	CcSEcCtD
Morphine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000187	CcSEcCtD
Morphine—Headache—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000186	CcSEcCtD
Morphine—Nausea—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000176	CcSEcCtD
Morphine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	4.85e-06	4.28e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.84e-06	4.27e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	4.84e-06	4.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.82e-06	4.26e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	4.77e-06	4.21e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.75e-06	4.19e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.75e-06	4.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.73e-06	4.18e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.73e-06	4.18e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.72e-06	4.17e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.72e-06	4.17e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.72e-06	4.17e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	4.72e-06	4.16e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	4.71e-06	4.16e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.69e-06	4.14e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.68e-06	4.13e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.67e-06	4.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	4.67e-06	4.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	4.67e-06	4.12e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.66e-06	4.11e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.65e-06	4.1e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.62e-06	4.08e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.62e-06	4.08e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	4.62e-06	4.07e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.61e-06	4.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.59e-06	4.05e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.57e-06	4.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.57e-06	4.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.57e-06	4.03e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.57e-06	4.03e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.57e-06	4.03e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.56e-06	4.02e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	4.55e-06	4.01e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.54e-06	4.01e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.53e-06	3.99e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.52e-06	3.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.49e-06	3.97e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.49e-06	3.97e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.49e-06	3.97e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	4.47e-06	3.95e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.47e-06	3.95e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.47e-06	3.94e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.46e-06	3.94e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.45e-06	3.92e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.41e-06	3.89e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	4.38e-06	3.86e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.37e-06	3.86e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.35e-06	3.84e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.31e-06	3.8e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.3e-06	3.79e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.29e-06	3.78e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.28e-06	3.78e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.24e-06	3.74e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.24e-06	3.74e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.24e-06	3.74e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.24e-06	3.74e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	4.19e-06	3.69e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.19e-06	3.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.16e-06	3.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.12e-06	3.64e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.11e-06	3.63e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.08e-06	3.6e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.07e-06	3.59e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.07e-06	3.59e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.05e-06	3.57e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.05e-06	3.57e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.03e-06	3.56e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.02e-06	3.55e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.96e-06	3.5e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.96e-06	3.49e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.92e-06	3.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.9e-06	3.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.9e-06	3.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.9e-06	3.44e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.9e-06	3.44e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.89e-06	3.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.89e-06	3.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.89e-06	3.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.89e-06	3.43e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	3.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.86e-06	3.4e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.86e-06	3.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.84e-06	3.39e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.84e-06	3.39e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.83e-06	3.38e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.83e-06	3.38e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.83e-06	3.38e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.81e-06	3.36e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.79e-06	3.34e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.78e-06	3.33e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.77e-06	3.33e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.76e-06	3.31e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.74e-06	3.3e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.73e-06	3.29e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.71e-06	3.27e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.68e-06	3.24e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.67e-06	3.24e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.67e-06	3.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.67e-06	3.23e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.59e-06	3.17e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.59e-06	3.16e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.58e-06	3.16e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.51e-06	3.1e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.47e-06	3.06e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.46e-06	3.06e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.44e-06	3.03e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.44e-06	3.03e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.42e-06	3.02e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.42e-06	3.02e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.42e-06	3.02e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.42e-06	3.01e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.42e-06	3.01e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.36e-06	2.96e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.36e-06	2.96e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.34e-06	2.95e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.34e-06	2.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.33e-06	2.94e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.3e-06	2.91e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.29e-06	2.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.25e-06	2.87e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.23e-06	2.85e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.22e-06	2.84e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.22e-06	2.84e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.2e-06	2.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.17e-06	2.8e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.17e-06	2.8e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.17e-06	2.79e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.17e-06	2.79e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.16e-06	2.79e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.15e-06	2.78e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.15e-06	2.78e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.12e-06	2.75e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.11e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.11e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.1e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.09e-06	2.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.09e-06	2.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.09e-06	2.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.07e-06	2.71e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.06e-06	2.7e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.05e-06	2.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.02e-06	2.66e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.01e-06	2.66e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3e-06	2.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3e-06	2.64e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.99e-06	2.64e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.99e-06	2.64e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.98e-06	2.63e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.98e-06	2.63e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.95e-06	2.61e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	2.6e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.94e-06	2.59e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.93e-06	2.59e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.92e-06	2.57e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-06	2.57e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.91e-06	2.56e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.91e-06	2.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.89e-06	2.55e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	2.54e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.87e-06	2.53e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.82e-06	2.49e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	2.48e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	2.79e-06	2.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.77e-06	2.44e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.77e-06	2.44e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.77e-06	2.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.75e-06	2.43e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.75e-06	2.42e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.74e-06	2.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.72e-06	2.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.72e-06	2.4e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	2.39e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.7e-06	2.38e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.69e-06	2.38e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.68e-06	2.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.66e-06	2.35e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.64e-06	2.33e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.63e-06	2.32e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.62e-06	2.31e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	2.29e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.57e-06	2.27e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.56e-06	2.26e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	2.26e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.55e-06	2.25e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.53e-06	2.24e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.53e-06	2.23e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.53e-06	2.23e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	2.22e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.5e-06	2.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.5e-06	2.21e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.47e-06	2.18e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.47e-06	2.18e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	2.14e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.42e-06	2.13e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.4e-06	2.12e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.4e-06	2.12e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-06	2.11e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-06	2.09e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	2.03e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.3e-06	2.03e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.26e-06	2e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.23e-06	1.97e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.22e-06	1.96e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	1.94e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	1.94e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.19e-06	1.93e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.12e-06	1.87e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	1.86e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.07e-06	1.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.07e-06	1.83e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	1.82e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.06e-06	1.82e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.03e-06	1.79e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.02e-06	1.78e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	1.78e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.01e-06	1.77e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.97e-06	1.74e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	1.7e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.92e-06	1.69e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.92e-06	1.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.92e-06	1.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	1.67e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.88e-06	1.66e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.86e-06	1.64e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.84e-06	1.63e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.84e-06	1.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.79e-06	1.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.77e-06	1.56e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.76e-06	1.55e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.71e-06	1.5e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.7e-06	1.5e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.66e-06	1.47e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.61e-06	1.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-06	1.4e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.58e-06	1.39e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	1.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-06	1.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.35e-06	1.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.24e-06	1.09e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-06	1.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-06	9.55e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	8.94e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.83e-07	7.79e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.32e-07	7.34e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.44e-07	4.8e-06	CbGpPWpGaD
